Back to mobile site

Wells Fargo Downgrades bluebird bio (BLUE) to Equal Weight

August 10, 2021 6:08 AM EDT Send to a Friend
Wells Fargo analyst Yanan Zh downgraded bluebird bio (NASDAQ: BLUE) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login